Biofrontera (BFRI) shares jumped nearly 13% in recent Friday trading after the company raised $4.2 million from a private placement of a senior secured convertible note with its principal shareholders.
The three-year note bears a paid-in-kind annual interest of 10% and is secured by the company's assets, with the principal amount convertible into common shares at a fixed conversion price of $0.78 per share, the company said.
Biofrontera said it will use the proceeds to support its general operations and strategic investments, including its commercial and clinical development initiatives.
Price: 0.86, Change: +0.10, Percent Change: +12.78
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。